Actual Medicinal Product (AMP) Olbetam 250mg capsules (Pfizer Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Store in a dry place.

Provenance

This compatibility recommendation is derived from Olbetam 250mg capsules (Pfizer Ltd).

Generic
Acipimox
Formulation
Acipimox 250mg capsules
  • Acipimox
    • Acipimox 250mg capsules

      • Olbetam 250mg capsules (Pfizer Ltd)



Related Formulations (1)

compatible_special_measures logo Acipimox 250mg capsules